Skip to main content
Donate
  • Our work
    • Our approach
      • Fund
      • Enable
      • Conduct
    • Our impact
    • Funded projects
    • The ALS Global Research Initiative
    • Annual meeting
  • For scientists
    • Funding opportunities
    • Research cores
      • Target ALS Data Engine
      • Longitudinal Biofluids Core
      • Human Postmortem Tissue 
Core
      • Stem Cell Core
      • Reagents Core
      • Animal Models Core
      • Genomics Core
    • Latest research news
  • Understanding ALS
    • About ALS
    • The current state of research
    • Voices of ALS
  • Get involved
    • Participate in research
      • Community-Based Pop-Up Clinics
      • Global Natural History Study
      • Post-Mortem Tissue Donation
    • Ways to give
      • Corporate Sponsorship
      • Donor Advised Funds
    • Fundraise for ALS research
      • Ride for Target ALS
    • Join our community
    • Donate now
  • About us
    • Our mission
    • News and stories
    • Our team
    • Our founder
    • Our partners
    • Contact us
  • News and stories
Donate

Filters

Search

Filters
Filters Applied:
Sort by
  • PAGE

    Terms of Service

    FEBRUARY 5, 2026
    Placeholder image
  • PAGE

    Ride for Target ALS

    JANUARY 28, 2026
  • RESEARCH

    The ALS Global Research Initiative: Pioneering ALS Research Across the Globe

    JANUARY 27, 2026
  • NEWS

    Inside a Global Effort to Understand ALS Resilience

    JANUARY 27, 2026
  • NEWS

    Target ALS and Regeneron Partner to Expand Access to a Novel C9orf72 ALS/FTD Mouse Model

    JANUARY 27, 2026
    Placeholder image
  • RESEARCH NEWS

    Target ALS Grantee NRG Therapeutics Advances NRG5051 into Phase I Clinical Trial

    JANUARY 26, 2026
    Placeholder image
  • RESEARCH

    Target ALS Research Cores: Empowering Global ALS Discovery

    JANUARY 23, 2026
    Placeholder image
  • RESEARCH

    Driving Breakthroughs: Target ALS Grants Empower the Next Wave of ALS Research

    JANUARY 23, 2026
    Placeholder image
  • ANNOUNCEMENT

    Target ALS Launches New Website to Democratize ALS Research and Better Serve the Global ALS Community

    JANUARY 22, 2026
  • EXPERT INSIGHTS

    Harnessing the Power of Open Data: How the Target ALS Data Engine Accelerates Discovery for Global Scientists

    JANUARY 21, 2026

Explore More

  • Our Approach
  • Participate in research
  • News and stories
  • Privacy policy
  • Financial reports

Contact Us

  • Contact us
  • Search

Target ALS Foundation

244 Madison Avenue #1025

New York, NY 10016

(332) 333-4140

Stay Connected

We are a 501(c)(3) public charity (EIN: 81-0756743), eligible to receive tax-deductible contributions that directly support our mission to break down barriers to ALS research to find effective treatments.

The Target ALS (TALS) website is intended for informational purposes only. Opinions expressed may not be that of TALS or its employees. Learn more in our Privacy Policy and Terms of Service.

Candid certification

© 2026 Target ALS Foundation, Inc. | Our vision is a world where Everyone Lives